FDA Enforcement · Jun 24, 2026
Drug recall: Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle
Failed Dissolution Specifications — Inventia Healthcare Limited · Class II · Ongoing · 11,460 bottles
Latest medical news · page 150
The latest headlines across every section, pulled from official and open-access sources.
FDA Enforcement · Jun 24, 2026
Drug recall: Quala Dental Products, Topical Anesthetic Gel, 20 % Benzocaine, Strawberry Flavor Net Contents: 1 oz (30…
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
FDA Enforcement · Jun 24, 2026
Drug recall: Lucky Super Soft, Antifungal Athlete's Foot Cream, Clotrimazole 1% Cream
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1102 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Med Pride, HYDROCORTISONE CREAM 1%
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 4,738 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Med Pride, Bacitracin Zinc Ointment, 500 units, 1oz (28.3g) tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 4374 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 50 Grams Activated Charcoal in 240 ml…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
FDA Enforcement · Jun 24, 2026
Drug recall: VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 25 Grams Activated Charcoal in 26…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
FDA Enforcement · Jun 24, 2026
Drug recall: VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 25 Grams Activated Charcoal in 120 ml…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
FDA Enforcement · Jun 24, 2026
Drug recall: Aripiprazole Tablets USP
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. — Ajanta Pharma USA Inc · Class II · Ongoing · 6,143 bottles
FDA Enforcement · Jun 24, 2026
Drug recall: Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz (30 mL)
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
FDA Enforcement · Jun 24, 2026
Drug recall: Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ (30 g)
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 450 units
FDA Enforcement · Jun 24, 2026
Drug recall: Lil Drug Store, Triple Antibiotic Ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg),…
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1225 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: safco SensiCaine-Ultra (20% Benzocaine), Topical Anesthetic Gel, Strawberry Flavor, 1 oz. (29.6mL)
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
FDA Enforcement · Jun 24, 2026
Drug recall: Med Pride, 1% Clotrimazole Antifungal Cream
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 5755 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle
Labeling: Incorrect or Missing Lot and/or Exp Date — Sandoz Inc · Class III · Ongoing · 7,803 bottles
FDA Enforcement · Jun 24, 2026
Drug recall: Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg, Polymyxin B 5000…
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 8996 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1…
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities. — Glenmark Pharmaceuticals Inc., USA · Class II · Ongoing
FDA Enforcement · Jun 24, 2026
Drug recall: Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B…
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 2420 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton
Crystallization; identified as Buprenorphine free base — Par Health USA, LLC · Class II · Ongoing · 46,334 units
FDA Enforcement · Jun 24, 2026
Drug recall: Pearson Quality Topical Anesthetic Gel (20% Benzocaine), Mint Flavor, Net Contents: 1 oz (3o g)
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 900 units
FDA Enforcement · Jun 24, 2026
Drug recall: VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 50 Grams Activated Charcoal in 52…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
FDA Enforcement · Jun 24, 2026
Drug recall: Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) tubes, Dist by/por: Pharmadel LLC, New Castle,…
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 84 tubes
FDA Enforcement · Jun 24, 2026
Drug recall: Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1087 tubes
FDA Enforcement · Jun 24, 2026
Device recall: MEDLINE Medical Procedure Kits labeled as: 1) BASIC HEART PACK, Medline Kit/SKU DYNJ67331B; 2) CARDIAC…
During an internal review, Medline identified representative samples did not meet applicable performance specifications. Identified issues include irregularities in catheter surface finish, instances where the catheter connector detached prematurely from the catheter funnel, and limited cases where the catheter outer diameter did not meet specification. — Medline Industries, LP · Class II · Ongoing · 4801 units